The aim of the event is to offer case studies and insight into how to effectively outsource and manager clinical trials throughout East Asia. The programme incorporates insight from both small and big pharma and sessions will take place in both English and Korean.

This year’s event is taking place in Seoul, (South Korea) where there is a good balance of local and global pharma companies. Korea has made huge steps towards being recognised as a key player in pharma by specialising in biosimilar

Why South Korea?

The event is taking place in South Korea, this is because there is a good balance of local and global pharma companies. Korea also has made huge steps towards being recognised as a key player in pharma by specialising in biosimilar.

To learn more about this event, and to register online, visit https://goo.gl/cGi5Qy